INVO Bioscience (INVO) Short Interest Ratio & Short Volume $0.80 +0.05 (+6.68%) (As of 11/1/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends INVO Bioscience Short Interest DataINVO Bioscience (INVO) has a short interest of 2,000 shares, representing 0.05% of the float (the number of shares available for trading by the public). This marks a -96.60% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 1.59 million shares to cover all short positions.Current Short Interest2,000 sharesPrevious Short Interest58,900 sharesChange Vs. Previous Month-96.60%Dollar Volume Sold Short$1,420.00Short Interest Ratio0.0 Days to CoverLast Record DateSeptember 30, 2024Outstanding Shares3,809,000 sharesFloat Size3,880,000 sharesShort Percent of Float0.05%Today's Trading Volume99,743 sharesAverage Trading Volume1,587,563 sharesToday's Volume Vs. Average6% Short Selling INVO Bioscience? Sign up to receive the latest short interest report for INVO Bioscience and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartINVO Short Interest Over TimeINVO Days to Cover Over TimeINVO Percentage of Float Shorted Over Time Ad Crypto 101 MediaCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Click here to reserve your spot at the emergency crypto summit now. INVO Bioscience Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/30/20242,000 shares $1,420.00 -96.6%0.1%0 $0.71 9/15/202458,900 shares $41,989.81 -51.4%1.5%0.3 $0.71 8/31/2024121,300 shares $97,185.56 -20.0%3.1%0.6 $0.80 8/15/2024151,700 shares $128,945.00 -69.5%3.9%0.8 $0.85 7/31/2024496,600 shares $446,940.00 +2,541.5%13.1%2.5 $0.90 7/15/202418,800 shares $15,754.40 -9.2%0.5%0.1 $0.84 Get the Latest News and Ratings for INVO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for INVO Bioscience and its competitors with MarketBeat's FREE daily newsletter. 6/30/202420,700 shares $17,390.09 -72.6%0.6%0 $0.84 6/15/202475,600 shares $77,868.00 +144.7%2.0%0 $1.03 5/31/202430,900 shares $26,574.00 -62.0%0.8%0 $0.86 5/15/202481,300 shares $86,991.00 +146.4%2.2%0 $1.07 4/30/202433,000 shares $33,000.00 +87.5%1.2%0 $1.00 4/15/202417,600 shares $13,499.20 +45.5%0.7%0 $0.77 3/31/202412,100 shares $13,673.00 +10.0%0.5%0.4 $1.13 3/15/202411,000 shares $11,330.00 -1.8%0.5%0.4 $1.03 2/29/202411,200 shares $12,880.00 -24.3%0.5%0.2 $1.15 2/15/202414,800 shares $12,551.88 -32.4%0.6%0.1 $0.85 1/31/202421,900 shares $21,900.00 +2.3%0.9%0 $1.00 1/15/202421,400 shares $22,470.00 -51.0%0.9%0 $1.05 12/31/202343,700 shares $58,995.00 -24.4%1.8%0 $1.35 12/15/202357,800 shares $71,094.00 -70.6%N/A0 $1.23 11/30/2023196,700 shares $367,829.00 -80.3%N/A0.1 $1.87 11/15/2023997,200 shares $1.84 million +245.1%N/A0.3 $1.85 10/31/2023289,000 shares $375,700.00 +397.4%N/A0.2 $1.30 10/15/202358,100 shares $39,827.55 -52.7%N/A0 $0.69 9/30/2023122,700 shares $96,957.54 +740.4%N/A0.6 $0.79 9/15/202314,600 shares $15,184.00 -13.6%N/A0.1 $1.04 8/31/202316,900 shares $25,519.00 -86.7%N/A0.1 $1.51 8/15/2023127,400 shares $181,545.00 +182.5%N/A0.5 $1.43 7/31/202345,100 shares $223,696.00 -84.5%N/A0.2 $4.96 7/15/2023290,600 shares $51,145.60 -38.8%N/A0.2 $0.18 6/30/2023474,800 shares $95,054.96 +363.2%3.2%0.4 $0.20 6/15/2023102,500 shares $17,404.50 +94.5%0.8%0.1 $0.17 5/31/202352,700 shares $13,417.42 -28.6%0.4%0.1 $0.25 5/15/202373,800 shares $26,095.68 No Change0.6%0.4 $0.35 10/31/202259,200 shares $68,080.00 -17.2%N/A2.4 $1.15 10/15/202271,500 shares $88,660.00 +3.6%N/A2.8 $1.24 9/30/202269,000 shares $73,140.00 +102.9%N/A2.6 $1.06 9/15/202234,000 shares $49,640.00 +38.8%N/A1 $1.46 8/31/202224,500 shares $23,716.00 -63.6%N/A0.8 $0.97 8/15/202267,300 shares $76,049.00 +3.9%N/A1.5 $1.13Musk Says ‘Dollar Will Be Worth Nothing…’ (Ad)Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…All you have to do is claim your free ticket to the event now… 7/31/202264,800 shares $64,152.00 +19.8%N/A1.4 $0.99 7/15/202254,100 shares $51,936.00 -30.7%N/A1.1 $0.96 6/30/202278,100 shares $49,976.19 +65.5%N/A1.5 $0.64 6/15/202247,200 shares $41,819.20 -42.1%N/A0.9 $0.89 5/31/202281,500 shares $79,829.25 +13.5%N/A1.5 $0.98 5/15/202271,800 shares $101,956.00 +22.5%N/A1.9 $1.42 4/30/202258,600 shares $88,486.00 -34.0%N/A1.7 $1.51 4/15/202288,800 shares $166,944.00 -1.0%N/A2.1 $1.88 3/31/202289,700 shares $236,808.00 +27.1%N/A2.2 $2.64 3/15/202270,600 shares $154,614.00 +2.3%N/A1.6 $2.19 2/28/202269,000 shares $207,690.00 +63.5%N/A1.5 $3.01 2/15/202242,200 shares $127,022.00 -44.2%N/A1 $3.01 1/31/202275,600 shares $240,408.00 -12.7%N/A1.5 $3.18 1/15/202286,600 shares $312,626.00 -1.5%N/A0 $3.61 12/31/202187,900 shares $292,707.00 -26.1%N/A1.8 $3.33 12/15/2021119,000 shares $445,060.00 +104.1%N/A2.3 $3.74 11/30/202158,300 shares $179,564.00 -55.0%N/A1.1 $3.08 11/15/2021129,400 shares $427,020.00 +5.6%N/A2.6 $3.30 10/29/2021122,500 shares $422,625.00 +29.6%N/A2.7 $3.45 10/15/202194,500 shares $375,165.00 -13.6%N/A2.2 $3.97 9/30/2021109,400 shares $356,644.00 -17.3%N/A3 $3.26 9/15/2021132,200 shares $465,344.00 +20.8%1.4%4 $3.52 8/31/2021109,400 shares $421,190.00 -39.5%1.2%2.7 $3.85 8/13/2021180,700 shares $766,168.00 -14.0%1.9%4.3 $4.24 7/30/2021210,100 shares $895,026.00 +11.6%2.3%4.5 $4.26 7/15/2021188,200 shares $767,856.00 -13.4%2.0%3.2 $4.08 6/30/2021217,400 shares $1.01 million +13.3%2.3%3.1 $4.65 6/15/2021191,900 shares $871,226.00 -34.9%2.1%1.6 $4.54 5/28/2021294,800 shares $1.29 million +0.9%3.2%1.4 $4.38 5/14/2021292,200 shares $1.13 million -7.6%3.2%0.2 $3.86 4/30/2021316,100 shares $1.33 million +11.8%3.5%0.2 $4.22 4/15/2021282,700 shares $1.10 million +2.4%N/A0 $3.90 3/31/2021276,100 shares $1.36 million -5.9%3.1%0.1 $4.94 3/15/2021293,400 shares $1.53 million +1,646.4%3.5%0.2 $5.23 2/26/202116,800 shares $54,536.16 -15.6%0.2%0 $3.25 2/12/202119,900 shares $76,217.00 +7.6%0.2%0.3 $3.83 1/29/202118,500 shares $56,980.00 -29.7%0.2%0.3 $3.08 1/15/202126,300 shares $80,478.00 No Change0.3%0.6 $3.06 10/30/202024,000 shares $89,520.00 +220.0%N/A2.5 $3.73 10/15/20207,500 shares $31,091.25 +5.6%N/A0.6 $4.15 9/30/20207,100 shares $26,625.00 No ChangeN/A1.5 $3.75 9/15/20207,100 shares $28,684.00 -1.4%N/A1.2 $4.04 3/13/202028,900 shares $5,780.00 +381.7%N/A0.4 $0.20 2/28/20206,000 shares $1,500.00 +66.7%N/A0.1 $0.25 2/14/20203,600 shares $934.56 -71.2%N/A0 $0.26 1/31/202012,500 shares $3,093.75 -69.1%N/A0.2 $0.25 1/15/202040,400 shares $8,484.00 +4,388.9%N/A0.6 $0.21 12/31/2019900 shares $192.15 +12.5%N/A0 $0.21 INVO Short Interest - Frequently Asked Questions What is INVO Bioscience's current short interest? Short interest is the volume of INVO Bioscience shares that have been sold short but have not yet been closed out or covered. As of September 30th, investors have sold 2,000 shares of INVO short. 0.05% of INVO Bioscience's shares are currently sold short. Learn More on INVO Bioscience's current short interest. What is a good short interest percentage for INVO Bioscience? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.05% of INVO Bioscience's floating shares are currently sold short. Is INVO Bioscience's short interest increasing or decreasing? INVO Bioscience saw a decline in short interest during the month of September. As of September 30th, there was short interest totaling 2,000 shares, a decline of 96.6% from the previous total of 58,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is INVO Bioscience's float size? INVO Bioscience currently has issued a total of 3,809,000 shares. Some of INVO Bioscience's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. INVO Bioscience currently has a public float of 3,880,000 shares. How does INVO Bioscience's short interest compare to its competitors? 0.05% of INVO Bioscience's shares are currently sold short. Here is how the short interest of companies in the industry of "surgical & medical instruments" compare to INVO Bioscience: Autonomix Medical, Inc. (1.09%), STRATA Skin Sciences, Inc. (0.15%), SeaStar Medical Holding Co. (5.45%), Biotricity, Inc. (17.03%), PAVmed Inc. (3.21%), GlucoTrack, Inc. (0.72%), T2 Biosystems, Inc. (9.41%), NeuroMetrix, Inc. (1.45%), Plus Therapeutics, Inc. (0.94%), Carmell Co. (2.90%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.04 billion), AppLovin Co. ($2.69 billion), Nu Holdings Ltd. ($2.64 billion), Paychex, Inc. ($2.61 billion), Cencora, Inc. ($2.30 billion), Aptiv PLC ($2.09 billion), Moderna, Inc. ($2.09 billion), Tractor Supply ($2.04 billion), Coinbase Global, Inc. ($1.97 billion), and International Paper ($1.95 billion). View all of the most shorted stocks. What does it mean to sell short INVO Bioscience stock? Short selling INVO is an investing strategy that aims to generate trading profit from INVO Bioscience as its price is falling. INVO shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against INVO Bioscience? A short squeeze for INVO Bioscience occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of INVO, which in turn drives the price of the stock up even further. How often is INVO Bioscience's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INVO, twice per month. The most recent reporting period available is September, 30 2024. More Short Interest Resources from MarketBeat Related Companies AMIX Short Interest SSKN Short Interest ICU Short Interest BTCY Short Interest PAVM Short Interest GCTK Short Interest TTOO Short Interest NURO Short Interest PSTV Short Interest CTCX Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:INVO) was last updated on 11/2/2024 by MarketBeat.com Staff From Our PartnersEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding INVO Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share INVO Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
